Skip to main content
. 2023 Sep 4;20(3):199–205. doi: 10.4274/tjod.galenos.2023.91043

Table 4. Clinical features and cycle outcomes of women with normo-responders (Group-3) who had a rate of serum estradiol decline of more or less than 60%.

graphic file with name TJOG-20-199-g5.jpg